Clinical Trial Update: Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is comparing conjunctival goblet cell density in dry eye disease patients treated with Cyclosporine 0.1% in perfluorobutylpentane (Vevy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Cyclosporine 0.05% emulsion (generic) (Cyclosporine)
• VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Dry Eye Disease (DED) | Phase 4 | Status: NOT_YET_RECRUITING